Skip to main content
. Author manuscript; available in PMC: 2009 Jul 6.
Published in final edited form as: Physiol Behav. 2007 Jan 4;90(5):744–750. doi: 10.1016/j.physbeh.2006.12.014

Fig. 1.

Fig. 1

Consummatory intake of 40% lactose free milk solution infused through an intraoral fistula following PVH injection of 0.9% saline (SAL, 200 nl), neuropeptide Y (NPY, 78 pmol/200 nl), agouti-related protein (AGRP, 200pmol/200 nl), or norepinephrine (NE, 40 nmol/200 nl). Milk intake after NPY, AGRP and NE was significantly increased, compared to intake following PVH saline injections. Data are expressed as mean intraoral intake in ml ± SEM. (*P ≤ 0.01 vs intake after saline).